Rivaroxaban for system suitability CRS (Y0002193)
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Rivaroxaban for system suitability CRS (Y0002193)

● In Stock

Catalogue No.:PVE00473
CAS No.:N/A
Mol. Formula:-
Mol. Weight:-

Additional information on Rivaroxaban for system suitability CRS (Y0002193)

Parent drug

Rivaroxaban

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Description

The compound Rivaroxaban for system suitability CRS (Y0002193) is a highly characterized reference material that meets stringent regulatory standards | including those set by USP | EMA | JP | and BP. This product is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Rivaroxaban production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally | the product comes with a detailed Structure Elucidation Report (SER) | ensuring its precision and reliability for comprehensive analytical use.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url